A Randomised Controlled Trial Examining the Effectiveness of the New Recovery-oriented Creative Writing Group Intervention REWRITALIZE for People With Schizophrenia Spectrum Disorders
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 300
- 试验地点
- 6
- 主要终点
- Questionnaire for the process of recovery (QPR)
研究概览
简要总结
Health institutes call for psychosocial interventions and recovery-oriented approaches as supplement to pharmacological treatment for mental health disorders. Participatory art interventions have been suggested to be promising in promoting recovery by stimulating connectedness, hope, renegotiation of identity, participatory meaning-making and empowerment. Moreover, cognitive literature studies suggest there might be potential benefits of engaging with literature in terms of improved cognition and social cognition. In spite of promising findings, the evidence base is still thin. We have developed REWRITALIZE (REWR), a manualised, recovery-oriented fifteen-session participatory creative writing group intervention, led by a professional author and attended by a mental health professional. The intervention comprises introduction to literary forms, spontaneous writing on those forms, sharing texts and engaging in reflective discussions about them. It is designed to provide a holding and non-stigmatising environment.
The aim of the present study is to evaluate REWR for persons with severe mental illness. This study is a randomised controlled clinical trial (RCT) with an embedded pilot RCT focusing on clinical and personal recovery.
This study is an investigator-initiated, randomised, two-arm, single-blinded, multi-center, waiting list trial. Participants (n=266) with severe mental illness (>18 yrs.) will be recruited at six psychiatric centres in region Zealand and randomised to active (creative writing group + treatment as usual) or control (waiting list + treatment as usual) condition. Assessments will be collected pre- and post-intervention and six months after end of intervention. The primary outcome measure will be the questionnaire of the process of recovery administered at the end of the intervention. Secondary outcome measures comprise measures of recovery, self-efficacy and mentalising assessed at the end of the intervention and six months after the intervention ends. The post-intervention measures will be compared between active and control groups by means of independent sample t-tests. The pilot RCT will focus on a subset of participants (n=70) with schizophrenia spectrum disorders (18-35 yrs), evaluating exploratory outcome measures related perspective-taking, social cognition, cognitive function, psychosocial functioning, and symptom level.
详细描述
Objective: The study has three objectives. The primary objective is to determine if REWR in addition to standard mental healthcare is more effective than standard mental healthcare alone for promoting personal recovery. The secondary objective is to investigate if REWR in addition to standard mental healthcare is more effective than standard mental healthcare alone in promoting a. mentalising, b. self-efficacy, c. functioning and quality of life. The third objective is to explore if REWR in addition to standard mental healthcare furthers clinical recovery, namely cognition, social cognition, psychosocial functioning, and symptom reduction in a sample of young people with schizophrenia spectrum disorders.
Hypotheses: The main hypothesis is that people living with a schizophrenia spectrum disorder who participate in REWR as an add-on to standard mental healthcare, as compared to those that receive standard mental healthcare alone, will show a greater improvement in personal recovery, measured by the Questionnaire for the process of recovery (QPR) immediately after the end of the intervention (approximately 4.5 months post-baseline). Secondary hypotheses include that those who receive REWR in addition to standard mental healthcare will show a greater improvement in personal recovery, as well as mentalising, self-efficacy, clinical recovery and wellbeing immediately after the end of the intervention (approximately 4.5 months post-baseline), as well as six months later (approximately 10.5 months post-baseline).
Ethical considerations: Information about the studies is presented to all potential participants both verbally and in written form so they can make an informed decision about their participation before signing the informed consent forms. Research assistants will make clear to the candidates that participation is voluntary, and that withdrawal can occur at any time without consequence for treatment possibilities. Decisions regarding participation will not influence clinical care in any way. At the information meeting and in the informed consent form it will thus be made clear that the intervention is voluntary and safe, and that participants at any time can stop their participation in the project and withdraw their consent without any consequences for the standard treatment they receive. If the participants wish to withdraw from the experiment during the course, there are three options: 1) They withdraw from the intervention but not from the study, therefore they will participate in the data collection at the follow-ups. 2) They withdraw from both the intervention and the study, but data from the baseline measures can be used in the research project. 3) They withdraw from both the intervention and the study, and their data will be deleted.
The study will be conducted in agreement with the Declaration of Helsinki. The Regional ethical committee for the Capital Region has decided that the study is not required to seek approval under their legislation, which covers human participation in medical trials. We will adhere to all other ethical standards guiding good practice in research. The study has been registered with the Danish Data Protection Agency (p-2023-14655), and we will comply with all regulations regarding data security, and make sure that all technical solutions comply with GDPR regulations. The study will be registered at clinicaltrials.gov. If any modifications are made to the data collection or data analyses, these protocol amendments will be reported to the Danish Data Protection Agency and to clinicaltrials.gov.
The intervention is not expected to have any serious side-effects. This is supported by the pilot study and similar studies. The social setting can be associated with anxiety and discomfort, at least initially, as known from previous group start-ups. A mental health care professional will always be present in the group (the co-conductor, see REWRITALIZE under Interventions) and this is expected to reduce participants' distress and to regulate reactions including crisis following the group activity. Supportive sessions are offered by the co-conductor if needed.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Investigator, Outcomes Assessor)
盲法说明
Owing to the nature of the intervention, neither participants nor staff can be blinded to allocation. They will be instructed not to disclose the allocation status to the researchers. Baseline data will be collected prior to randomisation and the research clinicians and research assistant that collect follow-up data will be blinded. If he or she is unblinded during the follow-up assessments, for instance if the participant accidentally reveals his or her allocation status, the participant will be invited to another follow-up session, with a blinded assessor. An employee outside the research team will extract data from REDCap on study completion and group allocation will be coded with A and B to ensure blinding of the researchers while analysing data, interpretation of data, drawing conclusions, and writing up reports.
入排标准
- 年龄范围
- 18 Years 至 35 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Having a severe mental illness
- •Minimum 18 yrs. of age
- •Master Danish
排除标准
- •Aggressive or disruptive behaviour that hinders participation
研究组 & 干预措施
Active intervention arm
Participants allocated to active intervention arm will receive Rewritalize in addition to standard mental health care
干预措施: Rewritalize (Other)
Active intervention arm
Participants allocated to active intervention arm will receive Rewritalize in addition to standard mental health care
干预措施: Standard mental health care (Other)
Control arm
Participants allocated to the control arm will receive standard mental health care.
干预措施: Standard mental health care (Other)
结局指标
主要结局
Questionnaire for the process of recovery (QPR)
时间窗: Measured at baseline and immediately after the end of intervention (4.5 months after baseline)
Measure of overall personal recovery. Total score range: 0-60. High is better.
次要结局
- Questionnaire for the process of recovery (QPR)(Measured at baseline and six months after the end of intervention (10.5 months after baseline))
- Thwarted Belongingness Scale (TBS)(Measured at baseline and immediately after the end of intervention (4.5 months after baseline))
- Self efficacy for personal recovery (SEPRS)(Measured at baseline and immediately after the end of intervention (4.5 months after baseline))
- Mentalization scale (MentS)(Measured at baseline and immediately after the end of intervention (4.5 months after baseline))
- Toronto Alexithymia scale (TAS)(Measured at baseline and immediately after the end of intervention (4.5 months after baseline))
- The Manchester Short Assessment of Quality of life (MANSA)(Measured at baseline, immediately after the end of intervention (4.5 months after baseline))
- The Work and Social Adjustment Scale (WSAS)(Measured at baseline, immediately after the end of intervention (4.5 months after baseline))
研究者
Lene Falgaard Eplov
Head of Research, Associate professor
Amager Hospital
